PER-079-05已完成未知
PREDICTION OF RESPONSE AND TOXICITY IN PATIENTS WHO RECEIVE CHEMOTHERAPY FOR BREAST CANCER, CORRELATIVE STUDY OF GENOMICS, PROTEOMICS AND PHARMACOGENOMY
HOSSIER ONCOLOGY GROUP,0 个研究点目标入组 0 人开始时间: 2006年2月8日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 0 至 0（—）
入选标准
- •1. Histological and cytologic confirmation of locally advanced or metastatic breast adenocarcinoma.
- •2. Disease susceptible to pre-treatment core or incisional biopsy with adequate tissue sample for histology, and genomics / proteomics analysis.
- •3. Measurable and evaluated disease, between the 21 days prior to the start of the treatment protocol, using the RECIST criteria
- •4. Planning of chemotherapy with any of the study regimens.
- •5. Appropriate performance status and organic function.
- •6. Informed consent and authorization exempting the use of the
- •personal health information.
- •7. Absence of other uncontrolled or surgical medical conditions that the investigator considers may compromise participation in the study.
- •8. Woman over 18 years old.
排除标准
- •1. Any other uncontrolled medical or surgical condition that may compromise your participation in the study.
- •2. Pregnancy. A negative pregnancy test must be obtained between the 7 days prior to registration for treatment of the protocol in women of childbearing age.
- •3. Refusal to have adequate contraception control.
- •4. Breastfeeding.
研究者
相似试验
已完成
不适用
PREDICTION OF RESPONSE AND TOXICITY IN PATIENTS WHO RECEIVE PACLITAXEL AND AVASTIN FOR BREAST CANCER. A CORRELATIVE, MULTICENTRIC, GENOMIC, PROTEOMIC AND PHARMACOGENIC STUDY-C50 Malignant neoplasm of breastMalignant neoplasm of breastC50PER-009-08HOSSIER ONCOLOGY GROUP,
已完成
不适用
Prediction of the therapeutic response and adverse events to methotrexate by monitoring methotrexate-polyglutamates (MTX-PGs) concentration in erythrocytes in Japanese patients with rheumatoid arthritis (RA).Rheumatoid arthritisJPRN-UMIN000020134Jichi Medical University56
尚未招募
2 期
High dose radiotherapy in the treatment of advanced carcinoma cervix -a prospective studyCTRI/2023/07/055597Dr Anjan Bera
招募中
不适用
Prediction of therapy response and treatment outcomes in early course of schizophrenia.Subproject D1_AP2 of the research network ESPRIT (Enhancing Schizophrenia Prevention and Recovery through Innovative Treatments)DSM IV-TR:295.10-30, 295.90: Schizophrenia High Risc State of transmission to psychosisDRKS00010936Klinik und Poliklinik für Psychiatrie und Psychotherapie,LVR-Klinikum Düsseldorf / Kliniken der Heinrich Heine Universität Düsseldorf600
已完成
不适用
Prediction of outcomes and response to treatments with an ultrasensitive method for assessing intratumor epigenetic heterogeneity in colorectal cancerColorectal cancerJPRN-UMIN000021191Juntendo University Faculty of Medicine60